Clinical Trial Update: The Efficacy and Safety of Temozolomide in SDH-deficient GIST [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the efficacy and safety of temozolomide in SDH-deficient gastrointestinal stromal tumors and is currently recruiting, spo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Stromal Tumors

Drugs mentioned

• Temozolomide (Temozolomide)

Snippet

Sponsor: Asan Medical Center | Conditions: Gastrointestinal Stromal Tumors | Phase 2 | Status: RECRUITING